U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 204841

Expand all

SUMATRIPTAN (SUMATRIPTAN)
5MG/SPRAY
Marketing Status: Prescription
Active Ingredient: SUMATRIPTAN
Proprietary Name: SUMATRIPTAN
Dosage Form; Route of Administration: SPRAY; NASAL
Strength: 5MG/SPRAY
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A204841
Product Number: 001
Approval Date: Feb 19, 2016
Applicant Holder Full Name: LANNETT CO INC
Marketing Status:  Prescription
Patent and Exclusivity Information
SUMATRIPTAN (SUMATRIPTAN)
20MG/SPRAY
Marketing Status: Prescription
Active Ingredient: SUMATRIPTAN
Proprietary Name: SUMATRIPTAN
Dosage Form; Route of Administration: SPRAY; NASAL
Strength: 20MG/SPRAY
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A204841
Product Number: 002
Approval Date: Feb 19, 2016
Applicant Holder Full Name: LANNETT CO INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top